Area of research
Endocrinology, Diabetes and Metabolism · Molecular Biology
Research interest
Research interests include Diabetes Treatment and Management, Receptor Mechanisms and Signaling, Chemokine receptors and signaling, and Neuropeptides and Animal Physiology.
Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes
Altered desensitization and internalization patterns of rodent versus human glucose‐dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challenge
Progress on the development of Class A GPCR‐biased ligands
Loss of <i>Adgra3</i> causes obstructive azoospermia with high penetrance in male mice
Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic Phenotypes
Viral G Protein–Coupled Receptors Encoded by β- and γ-Herpesviruses
Epstein-Barr Virus-Encoded BILF1 Orthologues From Porcine Lymphotropic Herpesviruses Display Common Molecular Functionality
Structural basis for the constitutive activity and immunomodulatory properties of the Epstein-Barr virus-encoded G protein-coupled receptor BILF1
The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson’s Disease
A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor
Viral GPCR US28 can signal in response to chemokine agonists of nearly unlimited structural degeneracy
EBI2 in splenic and local immune responses and in autoimmunity
Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes
Rationally designed chemokine-based toxin targeting the viral G protein-coupled receptor US28 potently inhibits cytomegalovirus infection in vivo
International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors